Controlled drug delivery attributes of co-polymer micelles and xanthan-O-carboxymethyl hydrogel particles

International Journal of Biological Macromolecules

Volumn 70, Issue , 2014, Pages 37-43

  Maiti, Sabyasachi ^a   Mukherjee, Susweta ^a  

^a GUPTA COLLEGE OF TECHNOLOGICAL SCIENCES   (India)

Author keywords

Copolymer micelles; Dissolution efficiency; Hydrogel particles; Hypoglycemia; O Carboxymethylation; Xanthan polymer

Indexed keywords

COPOLYMER; GLIBENCLAMIDE; GLUCOSE; XANTHAN; ANTIDIABETIC AGENT; BACTERIAL POLYSACCHARIDE; DRUG CARRIER; GLUCOSE BLOOD LEVEL; HYDROGEL; MICELLE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GLUCOSE BLOOD LEVEL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MICELLE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; RABBIT; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG EFFECTS; INFRARED SPECTROSCOPY; SYNTHESIS;

ANIMALS; BLOOD GLUCOSE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLYBURIDE; HYDROGEL; HYPOGLYCEMIC AGENTS; MICELLES; PARTICLE SIZE; POLYMERS; POLYSACCHARIDES, BACTERIAL; RABBITS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84903853423     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.06.015     Document Type: Article

References (42)

1. Sweetman S.C. Martindale: The Complete Drug Reference 2002, Pharmaceutical Press, London.
2. Ghosh L.K., Thakur R.S., Sharma P.K., Ghosh N.C., Gupta B.K. Development and evaluation of an ideal formulation of glibenclamide by solid dispersion techniques. Boll. Chim. Farm 1998, 137:26-29.
3. Lobenberg R., Kramer J., Shah V.P., Amidon G.L., Dressman J.B. Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide. Pharm. Res. 2000, 17:439-444.
4. Tashtoush B.M., Al-Qashi Z.Z., Najib N.M. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems. Drug Dev. Ind. Pharm. 2004, 30:601-607.
5. Thompson D., Chaubal M.V. Cyclodextrins (CDS)-excipients by definition, drug delivery systems by function (part I: injectable applications). Drug Deliv. Technol. 2000, 2:34-38.
6. Obaidat A.A., Ababneh N.M. Improvement of glibenclamide bioavailability using cyclodextrin inclusion complex dispersed in polyethylene glycol. Jordan J. Pharm. Sci. 2009, 2:119-130.
7. Chowdary K.P.R., Hymavathi R. Enhancement of dissolution rate of glibenclamide. J. Pharm. Sci. 2001, 63:150-154.
8. Dastmalchi S., Garjani A., Maleki N., Sheikhee G., Baghchevan V., Jafari-Azad P., Valizadeh H., Barzegar-Jalali M. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. J. Pharm. Pharmaceut. Sci. 2005, 8:175-181.
9. Patel T.B., Patel L.D., Patel T.B., Makwana S.H., Patel T.R. Formulation and characterization of solid dispersions containing glibenclamide. Int. J. Pharmacy Pharm. Sci. 2010, 2:138-141.
10. Manimaran V., Damodharan N., Mothilal M., Rajkumar K., Chalackal R.M. Enhancement of dissolution rate of glibenclamide by solid dispersion technology. Int. J. Curr. Pharm. Res. 2010, 2:14-17.
11. Mudgal S.S., Pancholi S.S. Formulation of glibenclamide solid dispersions by solvent evaporation technique. J. Chem. Pharm. Res. 2012, 4:353-359.
12. Ghebremeskel A.N., Vemavarapu C. Surfactants as plasticizers in preparing solid dispersions. Int. J. Pharm. 2007, 328:119-129.
13. Mudgal S.S., Jayaprakash S., Nagrajan M., Pancholi S.S. Formulation and evaluation of tablets of micronized glibenclamide (Glyburide) in industrial set-up. Int. J. Pharm. Res. 2010, 2:25-29.
14. Ray R., Kibbe A.H., Rowe R., Shleskey P., Weller P. Handbook of Pharmaceutical Excipients 2003, APhA Publications, Washington, DC.
15. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47:113-131.
16. Kwon G.S. Block copolymer micelles as drug delivery systems. Adv. Drug Deliv. Rev. 2002, 54:167.
17. Dutta P., Dey J., Perumal V., Mandal M. Amino acid based amphiphilic copolymer micelles as a carrier of non-steroidal anti-inflammatory drugs: solubilization, in vitro release, and biological evaluation. Int. J. Pharm. 2011, 407:207-216.
18. Nair K.L., Jagadeeshan S., Nair S.A., Kumar G.S. Evaluation of triblock copolymeric micelles of δ-valerolactone and poly(ethylene glycol) as a competent vector for doxorubicin delivery against cancer. J. Nanobiotechnol. 2011, 25:42.
19. Ramaswamy M., Zhang X., Burt H.M., Wasan K.M. Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. J. Pharm. Sci. 1997, 86:460-464.
20. Ukawala M., Chaudhari K., Rajyaguru T., Manjappa A.S., Murthy R.S.R., Gude R. Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis. J. Drug Target 2012, 20:55-66.
21. Raveendran R., Bhuvaneshwar G.S., Sharma C.P. In vitro cytotoxicity and cellular uptake of curcumin-loaded pluronic/polycaprolactone micelles in colorectal adenocarcinoma cells. J. Biomater. Appl. 2013, 27:811-827.
22. Jiang G.B., Quan D., Liao K., Wang H. Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery. Mol. Pharm. 2006, 3:152-160.
23. Mekhail G.M., Kamel A.O., Awad G.A.S., Mortada N.D. Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan. Int. J. Biol. Macromol. 2012, 51:351-363.
24. Jeong Y.I., Kim D.H., Chung C.W., Yoo J.J., Choi K.H., Kim C.H., Ha S.H., Kang D.H. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(dl-lactide-co-glycolide) copolymer. Int. J. Nanomed. 2011, 6:1415-1427.
25. Du Y.Z., Weng Q., Yuan H., Hu F.-Q. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano 2010, 4:6894-6902.
26. Zhang C., Ding Y., Ping Q., Yu L.L. Novel chitosan-derived nanomaterials and their micelle-forming properties. J. Agric. Food Chem. 2006, 54:8409-8416.
27. Becker A., Katzen F., Pühler A., Ielpi L. Xanthan gum biosynthesis and application: a biochemical/genetic perspective. Appl. Microbiol. Biotechnol. 1998, 50:145-152.
28. Kang K.S., Pettitt D.J. Polysaccharides and their derivatives. Industrial Gums 1993, 341-397. Academic Press, California. R.L. Whistler, J.N. BeMiller (Eds.).
29. Peppas N.A., Bures P., Leobandung W., Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 2000, 50:27-46.
30. Park K., Qiu Y. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 2001, 53:321-339.
31. Maiti S., Ray S., Mandal B., Sarkar S., Sa B. Carboxymethyl xanthan microparticles as a carrier for protein delivery. J. Microencapsul. 2007, 24:743-756.
32. Kemp W. Organic Spectroscopy 1991, Macmillan, London, (Chapter 2).
33. Ostberg T., Lund E.M., Graffner C. Calcium alginate matrixes for oral multiple unit administration: IV. Release characteristics in different media. Int. J. Pharm. 1994, 112:241-248.
34. Kulkarni R.V., Sa B. Enteric delivery of ketoprofen through functionally modified poly(acrylamide-grafted-xanthan)-based pH-sensitive hydrogel beads: preparation, in vitro and in vivo evaluation. J. Drug Target 2008, 16:167-177.
35. Reddy T., Tammishetti S. Gastric resistant microbeads of metal ion-crosslinked carboxymethyl guar gum for oral drug delivery. J. Micriencapsul. 2002, 19:311-318.
36. Seely G.R., Hart R.L. Binding of aluminum and aluminium alizarin to alginate. Macromolecules 1976, 9:483-489.
37. Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50:47-60.
38. Khan K.A. The concept of dissolution efficiency. J. Pharm. Pharmacol. 1975, 27:48-49.
39. Korsmeyer R.W., Gurny R., Doelker E.M., Buri P., Peppas N.A. Mechanism of release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35.
40. Tabbakhian M., Hasanzadeh F., Tavakoli N., Jamshidian Z. Dissolution enhancement of glibenclamide by solid dispersion: solvent evaporation versus a supercritical fluid-based solvent-antisolvent technique. Res. Pharm. Sci. 2014, 9:337-350.
41. Abd Elbary A.A., Salem H.F., Maher M.E. In vitro and in vivo evaluation of glibenclamide using surface solid dispersion (SSD) approach. Br. J. Pharmacol. Toxicol. 2011, 2:51-62.
42. Kahn C.R., Shechter Y. Goodman and Gilman's the Pharmacological Basis of Therapeutics 1991, McGraw-Hill, New York. W.R. Theodore, S.N. Alan, P. Taylor, A.G. Gilman (Eds.).